The authors review the evolution of the treatments for persons with severe mental illnesses
over the past 40 years in three areas: pharmacological and other somatic treatments …

The importance of combining psychosocial and pharmacologic interventions for optimum
outcome in the treatment of schizophrenia is now well recognized. However, less research is …

The prevailing stress-vulnerability-protective factors model of schizophrenia helps the
clinician to understand the etiology, course, and treatment of this lifelong disorder. Stressors …

Schizophrenic patients are at increased risk for perioperative complications, as their
biological response to stress is impaired. The increased complications are associated with …

Antipsychotics have provided a great improvement in the management of people with
schizophrenia. The first generation antipsychotics could establish the possibility of …

Although life prevalence of substance use disorders among patients with schizophrenia is
close to 50%, few studies have been carried out to date to identify an integrated …

Substance abuse is highly prevalent in schizophrenia and associated with numerous
negative consequences. While studies have regularly reported more severe depressive …

The First Episode of Psychosis is the ideal book for patients experiencing the frightening and
confusing initial episode of psychosis, which often occurs during late adolescence or early …

The evidence-based practice movement rests on the premise that the scientific evidence
regarding treatment should be used judiciously to inform treatment decisions. This article …

The purpose of evidence-based medicine (EBM) is to enable patients—through the process
of collaboration with their health care providers—to take advantage of the best available …